Skip to main content

Table 1 Pain assessment of CRPS patients before and after PE

From: Exosome microRNA signatures in patients with complex regional pain syndrome undergoing plasma exchange

ID Age Sex Duration of CRPS (years) Pre PE NRS Post PE NRS HT (cm) WT (kg) BMI Response Comorbidities
P1 54 F 4 7 3 170 100.9 34.9 Good Hypothyroidism, B12 deficiency, Iron deficiency, GERD, Seizure,
P2 40 M 11 8 4 195 126 33.1 Good No past medical history other than CRPS
P3 57 M > 6 8 2 165 120 44.1 Good Asthma, DM, OSA, Hypercholestrolemia, Mitochondrial disease
P4 57 F > 6 8 7 163 51.63 19.4 Poor Fibromyalgia, Anemia
P5 28 F 7 7 7 160 81.1 31.7 Poor Grave’s disease, Polycystic ovary syndrome, Migraine, Von Willebrand disease
P6 26 F > 6 8 7 163 52.27 19.7 Poor Stiff man syndrome, Seizure disorder
  1. Pain assessment was conducted on CRPS patients before and 2 weeks following PE, using a numerical rating scale (NRS). CRPS patients with a difference in the NRS pain scores (pre PE-post PE) greater than three were considered as responders, while those less than three were classified as poor responders